Related Experiment Video
Updated: Apr 19, 2026

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts
Published on: November 5, 2012
Distinct DNA damage determines differential phosphorylation of Chk2
1a Department of Cancer Genetics; Roswell Park Cancer Center ; Buffalo , NY USA.
Abstract:
Checkpoint kinase 2 (Chk2) has been implicated in DNA damage signaling. By using BJ human fibroblasts, HCT116 colorectal cancer cells and HeLa cervical cancer cells, we further detailed phosphorylation kinetics of Chk2 under treatment with neocarcinostatin (NCS) or doxorubicin (Dox). After NCS treatment, phosphorylation of Chk2 Thr68 occurs in 3 min, followed by phosphorylation of Ser19 and Ser33/35. In ATM deficient fibroblasts, NCS does not induce phosphorylation of NBS1 Ser343 and Chk2 Ser19 and Ser33/35, however Chk2 Thr68 is still phosphorylated, indicating that ATM is essential for phosphorylation of these residues when treated with NCS. By using Chk2-deficient HCT116 cells re-expressing phospho-mutant Chk2 (T68A), we found that inhibition of Thr68 phosphorylation enhances Ser19 phosphorylation in NCS treated cells. Interestingly, in contrast to NCS, Dox does not induce Ser33/35 phosphorylation in HeLa and HCT116 cells. Phosphorylation of Thr68 is sustained until 3 to 4 hours, and phosphorylation of Ser19 occurs 70 to 80 min after Dox treatment. These results demonstrate that Chk2 s involved in the early stages of DNA damage response. Differential phosphorylation kinetics of these residues suggests that DNA damage determines intermolecular and intramolecular interaction of Chk2, which may regulate phosphorylation.
Insights
Checkpoint kinase 2 (Chk2) phosphorylation kinetics were detailed following DNA damage. ATM is essential for Chk2 phosphorylation, and its specific residues are differentially regulated by DNA damage type.
Area of Science:
- Cellular biology
- Molecular oncology
- DNA damage response
Background:
- Checkpoint kinase 2 (Chk2) is a key player in cellular responses to DNA damage.
- Understanding Chk2 phosphorylation dynamics is crucial for elucidating DNA repair pathways.
Purpose of the Study:
- To investigate the detailed phosphorylation kinetics of Chk2 upon exposure to different DNA-damaging agents.
- To determine the role of ATM (Ataxia-telangiectasia mutated) in Chk2 phosphorylation.
- To explore how specific Chk2 phosphorylation sites are regulated by DNA damage.
Main Methods:
- Utilized human fibroblast (BJ) and colorectal cancer (HCT116) and cervical cancer (HeLa) cell lines.
- Treated cells with neocarzinostatin (NCS) or doxorubicin (Dox) to induce DNA damage.
- Employed Chk2-deficient cells re-expressing phospho-mutant Chk2 (T68A) and ATM-deficient fibroblasts.
Main Results:
- NCS treatment rapidly induced Chk2 Thr68 phosphorylation, followed by Ser19 and Ser33/35.
- ATM is essential for NCS-induced phosphorylation of NBS1 Ser343 and Chk2 Ser19/Ser33/35, but not Thr68.
- Inhibition of Thr68 phosphorylation enhanced Ser19 phosphorylation in NCS-treated cells.
- Doxorubicin induced sustained Thr68 phosphorylation and delayed Ser19 phosphorylation, but did not induce Ser33/35 phosphorylation.
Conclusions:
- Chk2 is involved in the early stages of the DNA damage response.
- Differential phosphorylation kinetics of Chk2 residues suggest DNA damage-specific regulation of Chk2 interactions and activity.
- ATM plays a critical role in mediating Chk2 phosphorylation in response to specific DNA damage.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Fixing Double-strand Breaks
Homologous Recombination

